Stock data
Revelation Biosciences, Inc. (REVB)
Revelation Biosciences, Inc. (REVB) reported net income of -US$8.91M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$9.07M | -US$8.91M | — |
| 2024 | — | — | -US$7.98M | -US$15.04M | — |
| 2023 | — | — | -US$8.66M | -US$0.12M | — |
| 2022 | — | — | -US$10.86M | -US$10.83M | — |
| 2021 | — | — | -US$11.95M | -US$11.99M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$3.32M | — |
| 2026-03-31 | — | -US$3.01M | — |
| 2025-12-31 | — | -US$2.51M | — |
| 2025-09-30 | — | -US$1.91M | — |
| 2025-06-30 | — | -US$2.44M | — |
| 2025-03-31 | — | -US$2.05M | — |
| 2024-12-31 | — | -US$1.73M | — |
| 2024-09-30 | — | -US$2.24M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.